Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis: Letters to the Editors

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 6, 2010, Pages 676-677

  Romano, C ^a   Comito, D ^a   Famiani, A ^a   Fries, W ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; C REACTIVE PROTEIN; STEROID; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SHORT COURSE THERAPY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEDIATRICS; REMISSION INDUCTION; TACROLIMUS; TREATMENT OUTCOME;

EID: 76449104452     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04213.x     Document Type: Letter

References (4)

1. Yamamoto S, Nakase H, Mikami S, et al. Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther 2008 28 : 589 597.
2. Ogata H, Matsui T, Nakamura M, et al. A randomized dose finding study of oral tacrolimus therapy in refractory ulcerative colitis. Gut 2006 55 : 1255 1262.
3. Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 2000 137 : 794 799.
4. Ziring DA, Wu SS, Mow WS, et al. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children. J Pediatr Gastroenterol Nutr 2007 45 : 306 311.